Paper31602467
Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.
Medina D and 1 other. Am J Hypertens, 2019. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Angiotensin-(1-7): Translational Avenues in Cardiovascular Control. Papers, record 31602467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31602467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiotensin I | Major topic |
| Blood Pressure | Major topic |
| Cardiovascular System | Major topic |
| Hypertension | Major topic |
| Peptide Fragments | Major topic |
| Renin-Angiotensin System | Major topic |
| Animals | |
| Antihypertensive Agents | |
| Humans | |
| Signal Transduction | |
| Vasodilator Agents |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R00 HL122507 | NHLBI NIH HHS | United States | R00HL122507 | PubMed and NIH | NIH RePORTER |
| UL1 TR002014 | NCATS NIH HHS | United States | UL1TR002014 | PubMed and NIH | NIH RePORTER |
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22482038 | Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats. | Int J Hypertens | 2012 | https://conductscience.org/library/papers/22482038 | PubMed |
| 2 | 20936939 | Renin release: sites, mechanisms, and control. | Annu Rev Physiol | 2011 | https://conductscience.org/library/papers/20936939 | PubMed |
| 3 | 22595130 | Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction. | Regul Pept | 2012 | https://conductscience.org/library/papers/22595130 | PubMed |
| 4 | 26406236 | Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis. | PLoS One | 2015 | https://conductscience.org/library/papers/26406236 | PubMed |
| 5 | 21367658 | Angiotensin peptides and central autonomic regulation. | Curr Opin Pharmacol | 2011 | https://conductscience.org/library/papers/21367658 | PubMed |
| 6 | 29903860 | A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. | Eur Respir J | 2018 | https://conductscience.org/library/papers/29903860 | PubMed |
| 7 | 20111697 | ACE2 activation promotes antithrombotic activity. | Mol Med | 2010 | https://conductscience.org/library/papers/20111697 | PubMed |
| 8 | 29351514 | The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). | Physiol Rev | 2018 | https://conductscience.org/library/papers/29351514 | PubMed |
| 9 | 29712882 | Angiotensin generation in the brain: a re-evaluation. | Clin Sci (Lond) | 2018 | https://conductscience.org/library/papers/29712882 | PubMed |
| 10 | 11463766 | Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension. | Hypertension | 2001 | https://conductscience.org/library/papers/11463766 | PubMed |
| 11 | 20676968 | The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1/Smad2 expression. | Heart Vessels | 2010 | https://conductscience.org/library/papers/20676968 | PubMed |
| 12 | 17056670 | The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. | Am J Physiol Heart Circ Physiol | 2007 | https://conductscience.org/library/papers/17056670 | PubMed |
| 13 | 23718715 | Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts. | Clin Sci (Lond) | 2013 | https://conductscience.org/library/papers/23718715 | PubMed |
| 14 | 19861349 | The angiotensin II type 2 receptor in cardiovascular disease. | J Renin Angiotensin Aldosterone Syst | 2010 | https://conductscience.org/library/papers/19861349 | PubMed |
| 15 | 19923158 | Angiotensin-converting enzyme 2: a new target for neurogenic hypertension. | Exp Physiol | 2010 | https://conductscience.org/library/papers/19923158 | PubMed |
| 16 | 30413906 | The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. | Clin Auton Res | 2019 | https://conductscience.org/library/papers/30413906 | PubMed |
| 17 | 18026570 | The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. | Mol Med | 2008 | https://conductscience.org/library/papers/18026570 | PubMed |
| 18 | 18809792 | Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. | Hypertension | 2008 | https://conductscience.org/library/papers/18809792 | PubMed |
| 19 | 10775575 | Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. | Hypertension | 2000 | https://conductscience.org/library/papers/10775575 | PubMed |
| 20 | 3702589 | Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. | Life Sci | 1986 | https://conductscience.org/library/papers/3702589 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42749884 | Coumarins in hypertension management: from vascular signaling pathways to clinical perspectives. | Hypertens Res | 2026 | https://conductscience.org/library/papers/42749884 | PubMed |
| 41170193 | Evaluation of myocardial classic and alternative pathways of the renin-angiotensin system in cholestasis-induced cardiac injury: A time-course experimental study in rats. | Iran J Basic Med Sci | 2025 | https://conductscience.org/library/papers/41170193 | PubMed |
| 40849780 | The Antioxidant and Anti-lipidemic Potential of Angiotensin-converting Enzyme Inhibitor (Ramipril) in L-NAME Hypertensive Rats. | Cardiovasc Hematol Agents Med Chem | 2026 | https://conductscience.org/library/papers/40849780 | PubMed |
| 40213148 | Angiotensin-(1-7) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications. | Front Physiol | 2025 | https://conductscience.org/library/papers/40213148 | PubMed |
| 40144934 | Autophagy fine-tuning by angiotensin-(1-9) in cultured rat cardiomyocytes. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40144934 | PubMed |
| 39996621 | A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19. | Adv Respir Med | 2025 | https://conductscience.org/library/papers/39996621 | PubMed |
| 39769086 | Angiotensin-(1-7) and Central Control of Cardiometabolic Outcomes: Implications for Obesity Hypertension. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769086 | PubMed |
| 39764460 | Comprehensive review on neprilysin (NEP) inhibitors: design, structure-activity relationships, and clinical applications. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39764460 | PubMed |
| 39253534 | Deciphering NF-kappaB pathways in smoking-related lung carcinogenesis. | EXCLI J | 2024 | https://conductscience.org/library/papers/39253534 | PubMed |
| 39234105 | Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39234105 | PubMed |
| 38397857 | Novel Insights into the Cardioprotective Effects of the Peptides of the Counter-Regulatory Renin-Angiotensin System. | Biomedicines | 2024 | https://conductscience.org/library/papers/38397857 | PubMed |
| 38362781 | Alternative Renin-Angiotensin System. | Hypertension | 2024 | https://conductscience.org/library/papers/38362781 | PubMed |
| 38275069 | Novel Strategies to Improve the Cardioprotective Effects of Cardioplegia. | Curr Cardiol Rev | 2024 | https://conductscience.org/library/papers/38275069 | PubMed |
| 37931519 | Aromatase enzyme: Paving the way for exploring aromatization for cardio-renal protection. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37931519 | PubMed |
| 36979641 | Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979641 | PubMed |
| 36843595 | Visceral fat and attribute-based medicine in chronic kidney disease. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36843595 | PubMed |
| 36481346 | Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-19 pandemic. | Biochem Pharmacol | 2023 | https://conductscience.org/library/papers/36481346 | PubMed |
| 36247425 | Does Dapagliflozin influence arterial stiffness and levels of circulating anti-aging hormone soluble Klotho in people with type 2 diabetes and kidney disease? Results of a randomized parallel group clinical trial. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36247425 | PubMed |
| 35629404 | Hormonal Regulation of Renal Fibrosis. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35629404 | PubMed |
| 34208939 | The Arcuate Nucleus of the Hypothalamus and Metabolic Regulation: An Emerging Role for Renin-Angiotensin Pathways. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34208939 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGT | 183 | PubTator's text mining | https://conductscience.org/library/genes/183 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31602467
GET https://conductscience.org/api/papers/v1/31602467/references?page=2